Dr. James Johnston, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 214 N Grand St, Clarence, MO 63437 Phone: 660-699-2432 Fax: 660-699-3873 |
Lynn Mcnaul, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 214 N Grand St, Clarence, MO 63437 Phone: 660-699-2432 Fax: 660-699-3873 |
Mrs. Alicyn Grace Magruder, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 214 N Grand St, Clarence, MO 63437 Phone: 660-699-2432 Fax: 660-699-3873 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference, announced today that it has obtained commitments from several investors to purchase 2.7 million shares of its common stock at $6.00 per share and warrants to purchase 540,000 shares of its common stock for gross proceeds of $16.2 million.
Why do people with a hereditary mutation of the red blood pigment hemoglobin not contract severe malaria? Scientists in the group headed by Prof. Michael Lanzer of the Department of Infectious Diseases at Heidelberg University Hospital have now solved this mystery.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutics, and EyeGate Pharma, the leader in non-invasive ocular drug delivery announced today that they will collaborate on the ocular delivery of RNAi therapeutics. Each party will contribute technology, expertise, and resources to the collaboration.
A new study offers the first atomic-scale view of an interaction between the HIV capsid - the protein coat that shepherds HIV into the nucleus of human cells - and a host protein known as cyclophilin A. This interaction is key to HIV infection, researchers say.
› Verified 3 days ago